HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study.

AbstractBACKGROUND:
Invasive candidiasis (IC) is a frequent and life-threatening infection in critically ill patients. The aim of this study was to evaluate the epidemiology of IC and the antifungal susceptibility of etiological agents in patients admitted to our surgical intensive care unit (SICU) in Spain.
METHODS:
We designed a prospective, observational, single center, population-based study in a SICU. We included all consecutive adult patients (≥18 years old) who had documented IC, either on admission or during their stay, between January 2012 and December 2013.
RESULTS:
There were a total of 22 episodes of IC in the 1149 patients admitted during the 24-month study. The overall IC incidence was 19.1 cases per 1000 admissions. Thirteen cases of IC (59.1%) were intra-abdominal candidiasis (IAC) and 9 (40.9%) were candidemias. All cases of IAC were patients with secondary peritonitis and severe sepsis or septic shock. The overall crude mortality rate was 13.6%; while, it was 33% in patients with candidemia. All patients with IAC survived, including one patient with concomitant candidemia. The most common species causing IC was Candida albicans (13; 59.1%) followed by Candida parapsilosis (5; 22.7%), and Candida glabrata (2; 9.1%). There was also one case each (4.5%) of Candida krusei and Candida tropicalis. Thus, the ratio of non-C. albicans (9) to C. albicans (13) was 1:1.4. There was resistance to fluconazole and itraconazole in 13.6% of cases. Resistance to other antifungals was uncommon.
CONCLUSIONS:
Candida parapsilosis was the second most common species after C. albicans, indicating the high prevalence of non-C. albicans species in the SICU. Resistance to azoles, particularly fluconazole, should be considered when starting an empirical treatment. Although IAC is a very frequent form of IC in critically ill surgical patients, prompt antifungal therapy and adequate source control appears to lead to a good outcome. However, our results are closely related to our ICU and any generalization must be taken with caution. Therefore, further investigations are needed.
AuthorsGerardo Aguilar, Carlos Delgado, Isabel Corrales, Ana Izquierdo, Estefanía Gracia, Tania Moreno, Esther Romero, Carlos Ferrando, José A Carbonell, Rafael Borrás, David Navarro, F Javier Belda
JournalBMC research notes (BMC Res Notes) Vol. 8 Pg. 491 (Sep 29 2015) ISSN: 1756-0500 [Electronic] England
PMID26415526 (Publication Type: Journal Article, Observational Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Antifungal Agents
Topics
  • Abdomen (microbiology, pathology)
  • Aged
  • Antifungal Agents (pharmacology)
  • Candida (drug effects, isolation & purification)
  • Candidiasis, Invasive (epidemiology, microbiology)
  • Drug Resistance, Fungal (drug effects)
  • Female
  • Humans
  • Intensive Care Units (statistics & numerical data)
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Spain (epidemiology)
  • Surgery Department, Hospital (statistics & numerical data)
  • Surgical Wound Infection (microbiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: